- Home
- NERV vs BSLK Comparison
NERV vs BSLK Comparison
Compare NERV & BSLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- BSLK
- Stock Information
- Founded
- NERV 2007
- BSLK 2009
- Country
- NERV United States
- BSLK United States
- Employees
- NERV N/A
- BSLK N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- BSLK
- Sector
- NERV Health Care
- BSLK
- Exchange
- NERV Nasdaq
- BSLK NYSE
- Market Cap
- NERV 12.4M
- BSLK 12.3M
- IPO Year
- NERV 2014
- BSLK N/A
- Fundamental
- Price
- NERV $1.52
- BSLK $6.12
- Analyst Decision
- NERV Hold
- BSLK
- Analyst Count
- NERV 1
- BSLK 0
- Target Price
- NERV $5.00
- BSLK N/A
- AVG Volume (30 Days)
- NERV 5.9K
- BSLK 66.7K
- Earning Date
- NERV 05-13-2025
- BSLK 05-12-2025
- Dividend Yield
- NERV N/A
- BSLK N/A
- EPS Growth
- NERV N/A
- BSLK N/A
- EPS
- NERV 0.82
- BSLK N/A
- Revenue
- NERV N/A
- BSLK $1,525,000.00
- Revenue This Year
- NERV N/A
- BSLK N/A
- Revenue Next Year
- NERV N/A
- BSLK N/A
- P/E Ratio
- NERV $1.95
- BSLK N/A
- Revenue Growth
- NERV N/A
- BSLK N/A
- 52 Week Low
- NERV $1.15
- BSLK $4.54
- 52 Week High
- NERV $3.69
- BSLK $340.40
- Technical
- Relative Strength Index (RSI)
- NERV 40.93
- BSLK N/A
- Support Level
- NERV $1.58
- BSLK N/A
- Resistance Level
- NERV $1.74
- BSLK N/A
- Average True Range (ATR)
- NERV 0.06
- BSLK 0.00
- MACD
- NERV -0.01
- BSLK 0.00
- Stochastic Oscillator
- NERV 0.00
- BSLK 0.00
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About BSLK BOLT PROJECTS HOLDINGS INC
Bolt Projects Holdings Inc develops and produces biomaterials products. Its flagship products from its Vegan Silk Technology Platform, b-silk and xl-silk, are a biodegradable and vegan protein polymer and a replacement for silicone elastomers in beauty and personal care.